Basic Fibroblast Growth Factor Binds Its Receptors, Is Internalized, and Stimulates DNA Synthesis in Balb/c3T3 Cells in the Absence of Heparan Sulfate*

We have investigated the interaction of basic fibroblast growth factor (bFGF) with its receptors and heparan sulfate proteoglycans (HSPG). It has been suggested that in the absence of HSPG, cells are not able to bind bFGF or respond to treatment with bFGF. In our studies, Balb/c3T3 fibroblasts were treated with 50 mM sodium chlorate to completely inhibit (99%) sulfation of proteoglycans. We found that bFGF was able to bind, be internalized, and stimulate DNA synthesis in the absence of HSPG in a dose-dependent manner. bFGF bound to its receptors on chlorate-treated cells with a lower apparent affinity and no change in receptor number. To determine if this decreased affinity bFGF-receptor interaction is functional, we quantitatively analyzed bFGF internalization and stimulation of DNA synthesis in control and chlorate-treated cells. Endocytotic rate constants (ke) for chlorate-treated and control cells were ke = 0.078 ± 0.022 min−1 and ke = 0.043 ± 0.012 min−1, respectively, suggesting that the process of bFGF internalization is not dramatically altered by HSPG. bFGF stimulated DNA synthesis to the same maximal level under both conditions, but chlorate-treated cells were significantly less responsive at low bFGF doses (∼10-fold increase in ED50). The differences observed for control and chlorate-treated cells in the dose-response curves for stimulation of DNA synthesis and receptor binding correlated directly, suggesting that receptors are equally capable of eliciting a mitogenic signal under both conditions. It is unlikely that these results are due to residual HSPG since heparinase (I and III) digestion of chlorate-treated cells had little effect. Although the presence of HSPG on the cell surface increases the affinity of bFGF for its receptors, our observations suggest that HSPG are not “absolutely” required for binding, internalization, or stimulation of mitogenic activity.

[1]  W. Casscells,et al.  Culture‐induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells , 1991, Journal of cellular physiology.

[2]  J. Escobedo,et al.  Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis , 1992, Nature.

[3]  A. Rapraeger,et al.  Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. , 1993, Journal of cell science.

[4]  H. G. Weder,et al.  Determination of binding parameters from Scatchard plots. Theoretical and practical considerations. , 1974, European journal of biochemistry.

[5]  D. Faller,et al.  Inhibition of platelet-derived growth factor-mediated signal transduction by transforming ras. Suppression of receptor autophosphorylation. , 1991, The Journal of biological chemistry.

[6]  C. Hopkins.  Internalization of polypeptide growth factor receptors and the regulation of transcription. , 1994, Biochemical pharmacology.

[7]  C. Yeaman,et al.  A quantitative solid-phase assay for identifying radiolabeled glycosaminoglycans in crude cell extracts. , 1989, Analytical biochemistry.

[8]  C L Cooney,et al.  Heparinase inhibits neovascularization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Quarto,et al.  Heparan sulfate proteoglycans as transducers of FGF-2 signalling. , 1994, Journal of cell science.

[10]  V. Baldin,et al.  Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. , 1990, The EMBO journal.

[11]  M. Jaye,et al.  Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells. , 1994, The Journal of biological chemistry.

[12]  G. Shipley,et al.  Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin‐binding EGF‐like growth factor activity , 1995, Journal of cellular physiology.

[13]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[14]  D. Moscatelli,et al.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells , 1987, Journal of cellular physiology.

[15]  E. Edelman,et al.  Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. , 1993, Circulation research.

[16]  E. Edelman,et al.  Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. , 1992, The Journal of clinical investigation.

[17]  D. Lauffenburger,et al.  Receptors: Models for Binding, Trafficking, and Signaling , 1993 .

[18]  J. Turnbull,et al.  Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. , 1994, The Journal of biological chemistry.

[19]  D. Givol,et al.  Complexity of FGF receptors: genetic basis for structural diversity and functional specificity , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  E. Edelman,et al.  Tissue engineered perivascular endothelial cell implants regulate vascular injury. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Edelman,et al.  Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. , 1992, Biochemistry.

[22]  J. Xu,et al.  An essential heparin-binding domain in the fibroblast growth factor receptor kinase. , 1993, Science.

[23]  D. Moscatelli,et al.  Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. , 1992, The Journal of biological chemistry.

[24]  B. Olwin,et al.  Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate , 1992, The Journal of cell biology.

[25]  B. Olwin,et al.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.

[26]  D. Moscatelli.  Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells , 1988, The Journal of cell biology.

[27]  P. Leder,et al.  Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. , 1992, The Journal of biological chemistry.

[28]  L. Cousens,et al.  Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. , 1993, The Journal of biological chemistry.

[29]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[30]  H. Wiley,et al.  The endocytotic rate constant. A cellular parameter for quantitating receptor-mediated endocytosis. , 1982, The Journal of biological chemistry.

[31]  J G Flanagan,et al.  Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells , 1992, Molecular and cellular biology.

[32]  G. Waksman,et al.  FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. , 1995, Science.

[33]  D. Johnson,et al.  Structural and functional diversity in the FGF receptor multigene family. , 1993, Advances in cancer research.

[34]  E. Edelman,et al.  Transforming growth factor beta 1 stimulates the production of basic fibroblast growth factor binding proteoglycans in Balb/c3T3 cells. , 1992, The Journal of biological chemistry.

[35]  J. Turnbull,et al.  Heparan sulphate: functional role as a modulator of fibroblast growth factor activity. , 1993, Biochemical Society transactions.

[36]  J. Lear,et al.  Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. , 1994, Biochemistry.

[37]  J. Teissié,et al.  Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0----G1 transition. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Yayon,et al.  Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis , 1994, Cell.

[39]  M. Klagsbrun,et al.  A dual receptor system is required for basic fibroblast growth factor activity , 1991, Cell.

[40]  M. Klagsbrun.  The fibroblast growth factor family: structural and biological properties. , 1989, Progress in growth factor research.

[41]  M. Jaye,et al.  Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. , 1992, Biochimica et biophysica acta.

[42]  R. Tripathi,et al.  Detection, quantification, and significance of basic fibroblast growth factor in the aqueous humor of man, cat, dog and pig. , 1992, Experimental eye research.

[43]  M. Jaye,et al.  Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation , 1994, Cell.

[44]  I. Mason.  The ins and outs of fibroblast growth factors , 1994, Cell.

[45]  D. Rifkin,et al.  Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. , 1994, The Journal of biological chemistry.